Xylem (NYSE:XYL) Stock Gets Downgrade from Argus

Key Points

• Argus downgraded Xylem to Hold from Buy. Analysts overall have a consensus Hold rating and an average price target of $121.31.
• Xylem’s latest quarter fell short of expectations: earnings were $1.44 per share versus $1.45 expected, and revenue of $2.20 billion missed the $2.28 billion estimate, declining 3% year over year.
• A company director bought 11,000 shares at an average price of $89.60, increasing his stake by more than eightfold.

Xylem (NYSE:XYL - Get Free Report) was downgraded by Argus from a "buy" rating to a "hold" rating in a report released on Wednesday, MarketBeat reports.

A number of other research firms have also issued reports on XYL. Wolfe Research began coverage on Xylem in a report on Tuesday, September 15th. They issued a "peer perform" rating for the company. Mizuho set a $99.00 target price on Xylem in a research report on Wednesday, October 28th. Royal Bank Of Canada lowered their price target on Xylem from $135.00 to $125.00 and set an "outperform" rating on the stock in a report on Wednesday, October 28th. UBS Group dropped their price target on Xylem from $112.00 to $99.00 and set a "neutral" rating on the stock in a research report on Thursday, October 29th. Finally, The Goldman Sachs Group dropped their price target on Xylem from $160.00 to $138.00 and set a "buy" rating on the stock in a research report on Wednesday, October 28th. Nine equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, Xylem has a consensus rating of "Hold" and an average target price of $121.31.

Xylem Stock Down 1.2%

Shares of NYSE:XYL opened at $96.08 on Wednesday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.02 and a current ratio of 1.39. The company has a market cap of $22.04 billion, a PE ratio of 21.26, a price-to-earnings-growth ratio of 1.62 and a beta of 1.01. Xylem has a 52 week low of $87.40 and a 52 week high of $152.43. The firm has a 50 day simple moving average of $104.36 and a 200 day simple moving average of $117.13.

Xylem (NYSE:XYL - Get Free Report) last posted its quarterly earnings data on Tuesday, October 27th. The industrial products company reported $1.44 EPS for the quarter, missing analysts' consensus estimates of $1.45 by ($0.01). Xylem had a return on equity of 12.06% and a net margin of 11.94%. The firm had revenue of $2.20 billion during the quarter, compared to analyst estimates of $2.28 billion. During the same period in the prior year, the business posted $1.37 EPS. The company's revenue for the quarter was down 3.0% on a year-over-year basis. As a group, research analysts expect that Xylem will post 5.45 earnings per share for the current year.

Insider Buying and Selling at Xylem

In related news, Director D Koch purchased 11,000 shares of the company's stock in a transaction dated Thursday, October 29th. The shares were acquired at an average cost of $89.60 per share, with a total value of $985,600.00. Following the completion of the purchase, the director owned 12,247 shares of the company's stock, valued at $1,097,331.20. The trade was a 882.12% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.32% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. XXEC Inc. bought a new stake in Xylem in the 2nd quarter valued at $850,841,000. BlackRock Inc. acquired a new stake in Xylem in the 2nd quarter worth $2,959,730,000. Bank of New York Mellon Corp bought a new position in shares of Xylem during the 2nd quarter worth about $552,313,000. Hsbc Holdings PLC bought a new position in shares of Xylem during the 2nd quarter worth about $319,785,000. Finally, Deutsche Bank AG bought a new position in shares of Xylem during the 2nd quarter worth about $223,165,000. Hedge funds and other institutional investors own 87.96% of the company's stock.

Xylem Company Profile

Xylem Inc NYSE: XYL is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company's products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.